Boston Sci Buys Asthma Treatment Maker For $443M
The deal calls for Boston Scientific to make an up-front payment of $193.5 million and additional payments of up to $250 million through 2019 if certain revenue-based goals are met. The deal is expected to close in the fourth quarter, subject to customary conditions, Boston Scientific said.
Sunnyvale, Calif.-based Asthmatx markets the...
To view the full article, register now.